Global Smart Inhaler Technology Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	169 Pages	TechNavio	August, 2024	INF19175815

Best Price Guarantee
Price	from $2,500
Length	169 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19175815

Global Smart Inhaler Technology Market 2024-2028

The smart inhaler technology market is forecasted to grow by USD 62.4 mn during 2023-2028, accelerating at a CAGR of 12.01% during the forecast period. The report on the smart inhaler technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of respiratory diseases, growing demand for connected healthcare system, and increasing healthcare expenditure.

Technavio's smart inhaler technology market is segmented as below:

By Application

Asthma
COPD

By Product

Inhalers
Nebulizers

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the availability of real-time feedback as one of the prime reasons driving the smart inhaler technology market growth during the next few years. Also, growing healthcare digitalization and rising technological advancements will lead to sizable demand in the market.

The report on the smart inhaler technology market covers the following areas:

Smart inhaler technology market sizing
Smart inhaler technology market forecast
Smart inhaler technology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smart inhaler technology market vendors that include 3M Co., Adherium Limited, Amiko Digital Health Ltd., AptarGroup Inc., AstraZeneca Plc, Cognita Labs, Cohero Health Inc., Findair Sp. z o. o., Infineon Technologies AG, Novartis AG, OPKO Health Inc., Philip Morris International Inc., ResMed Inc., Sensirion AG, and Teva Pharmaceutical Industries Ltd.. Also, the smart inhaler technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Smart Inhaler Technology Market 2018 - 2022; Historic Market Size - Data Table on Global Smart Inhaler Technology Market 2018 - 2022 ($ million); 4.2 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 6.3 Asthma - Market size and forecast 2023-2028; Chart on Asthma - Market size and forecast 2023-2028 ($ million); Data Table on Asthma - Market size and forecast 2023-2028 ($ million); Chart on Asthma - Year-over-year growth 2023-2028 (%); Data Table on Asthma - Year-over-year growth 2023-2028 (%); 6.4 COPD - Market size and forecast 2023-2028; Chart on COPD - Market size and forecast 2023-2028 ($ million); Data Table on COPD - Market size and forecast 2023-2028 ($ million); Chart on COPD - Year-over-year growth 2023-2028 (%); Data Table on COPD - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 7.3 Inhalers - Market size and forecast 2023-2028; Chart on Inhalers - Market size and forecast 2023-2028 ($ million); Data Table on Inhalers - Market size and forecast 2023-2028 ($ million); Chart on Inhalers - Year-over-year growth 2023-2028 (%); Data Table on Inhalers - Year-over-year growth 2023-2028 (%); 7.4 Nebulizers - Market size and forecast 2023-2028; Chart on Nebulizers - Market size and forecast 2023-2028 ($ million); Data Table on Nebulizers - Market size and forecast 2023-2028 ($ million); Chart on Nebulizers - Year-over-year growth 2023-2028 (%); Data Table on Nebulizers - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 3M Co.; 3M Co. - Overview; 3M Co. - Business segments; 3M Co. - Key news; 3M Co. - Key offerings; 3M Co. - Segment focus; 12.4 Adherium Limited; Adherium Limited - Overview; Adherium Limited - Product / Service; Adherium Limited - Key offerings; 12.5 Amiko Digital Health Ltd.; Amiko Digital Health Ltd. - Overview; Amiko Digital Health Ltd. - Product / Service; Amiko Digital Health Ltd. - Key offerings; 12.6 AptarGroup Inc.; AptarGroup Inc. - Overview; AptarGroup Inc. - Business segments; AptarGroup Inc. - Key news; AptarGroup Inc. - Key offerings; AptarGroup Inc. - Segment focus; 12.7 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.8 Cognita Labs; Cognita Labs - Overview; Cognita Labs - Product / Service; Cognita Labs - Key offerings; 12.9 Cohero Health Inc.; Cohero Health Inc. - Overview; Cohero Health Inc. - Product / Service; Cohero Health Inc. - Key offerings; 12.10 Findair Sp. z o. o.; Findair Sp. z o. o. - Overview; Findair Sp. z o. o. - Product / Service; Findair Sp. z o. o. - Key offerings; 12.11 Infineon Technologies AG; Infineon Technologies AG - Overview; Infineon Technologies AG - Business segments; Infineon Technologies AG - Key news; Infineon Technologies AG - Key offerings; Infineon Technologies AG - Segment focus; 12.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.13 OPKO Health Inc.; OPKO Health Inc. - Overview; OPKO Health Inc. - Business segments; OPKO Health Inc. - Key offerings; OPKO Health Inc. - Segment focus; 12.14 Philip Morris International Inc.; Philip Morris International Inc. - Overview; Philip Morris International Inc. - Business segments; Philip Morris International Inc. - Key offerings; Philip Morris International Inc. - Segment focus; 12.15 ResMed Inc.; ResMed Inc. - Overview; ResMed Inc. - Business segments; ResMed Inc. - Key news; ResMed Inc. - Key offerings; ResMed Inc. - Segment focus; 12.16 Sensirion AG; Sensirion AG - Overview; Sensirion AG - Product / Service; Sensirion AG - Key news; Sensirion AG - Key offerings; 12.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Smart Inhaler Technology Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Application - Market share 2023-2028 (%); Exhibits33: Data Table on Application - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Application; Exhibits35: Data Table on Comparison by Application; Exhibits36: Chart on Asthma - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Asthma - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Asthma - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Asthma - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on COPD - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on COPD - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on COPD - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on COPD - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Application ($ million); Exhibits45: Data Table on Market opportunity by Application ($ million); Exhibits46: Chart on Product - Market share 2023-2028 (%); Exhibits47: Data Table on Product - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Product; Exhibits49: Data Table on Comparison by Product; Exhibits50: Chart on Inhalers - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Inhalers - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Inhalers - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Inhalers - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Nebulizers - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Nebulizers - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Nebulizers - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Nebulizers - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Product ($ million); Exhibits59: Data Table on Market opportunity by Product ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: 3M Co. - Overview; Exhibits110: 3M Co. - Business segments; Exhibits111: 3M Co. - Key news; Exhibits112: 3M Co. - Key offerings; Exhibits113: 3M Co. - Segment focus; Exhibits114: Adherium Limited - Overview; Exhibits115: Adherium Limited - Product / Service; Exhibits116: Adherium Limited - Key offerings; Exhibits117: Amiko Digital Health Ltd. - Overview; Exhibits118: Amiko Digital Health Ltd. - Product / Service; Exhibits119: Amiko Digital Health Ltd. - Key offerings; Exhibits120: AptarGroup Inc. - Overview; Exhibits121: AptarGroup Inc. - Business segments; Exhibits122: AptarGroup Inc. - Key news; Exhibits123: AptarGroup Inc. - Key offerings; Exhibits124: AptarGroup Inc. - Segment focus; Exhibits125: AstraZeneca Plc - Overview; Exhibits126: AstraZeneca Plc - Product / Service; Exhibits127: AstraZeneca Plc - Key news; Exhibits128: AstraZeneca Plc - Key offerings; Exhibits129: Cognita Labs - Overview; Exhibits130: Cognita Labs - Product / Service; Exhibits131: Cognita Labs - Key offerings; Exhibits132: Cohero Health Inc. - Overview; Exhibits133: Cohero Health Inc. - Product / Service; Exhibits134: Cohero Health Inc. - Key offerings; Exhibits135: Findair Sp. z o. o. - Overview; Exhibits136: Findair Sp. z o. o. - Product / Service; Exhibits137: Findair Sp. z o. o. - Key offerings; Exhibits138: Infineon Technologies AG - Overview; Exhibits139: Infineon Technologies AG - Business segments; Exhibits140: Infineon Technologies AG - Key news; Exhibits141: Infineon Technologies AG - Key offerings; Exhibits142: Infineon Technologies AG - Segment focus; Exhibits143: Novartis AG - Overview; Exhibits144: Novartis AG - Business segments; Exhibits145: Novartis AG - Key news; Exhibits146: Novartis AG - Key offerings; Exhibits147: Novartis AG - Segment focus; Exhibits148: OPKO Health Inc. - Overview; Exhibits149: OPKO Health Inc. - Business segments; Exhibits150: OPKO Health Inc. - Key offerings; Exhibits151: OPKO Health Inc. - Segment focus; Exhibits152: Philip Morris International Inc. - Overview; Exhibits153: Philip Morris International Inc. - Business segments; Exhibits154: Philip Morris International Inc. - Key offerings; Exhibits155: Philip Morris International Inc. - Segment focus; Exhibits156: ResMed Inc. - Overview; Exhibits157: ResMed Inc. - Business segments; Exhibits158: ResMed Inc. - Key news; Exhibits159: ResMed Inc. - Key offerings; Exhibits160: ResMed Inc. - Segment focus; Exhibits161: Sensirion AG - Overview; Exhibits162: Sensirion AG - Product / Service; Exhibits163: Sensirion AG - Key news; Exhibits164: Sensirion AG - Key offerings; Exhibits165: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits166: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits167: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits168: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits169: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits170: Inclusions checklist; Exhibits171: Exclusions checklist; Exhibits172: Currency conversion rates for US$; Exhibits173: Research methodology; Exhibits174: Information sources; Exhibits175: Data validation; Exhibits176: Validation techniques employed for market sizing; Exhibits177: Data synthesis; Exhibits178: 360 degree market analysis; Exhibits179: List of abbreviations